The University of Chicago Header Logo

Connection

John Fung to Tissue Donors

Back to Details
This is a "connection" page, showing publications John Fung has written about Tissue Donors.
John Fung
Connection Strength
2.703
Tissue Donors
  1. Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel. Liver Transpl. 2007 Dec; 13(12):1633-6.
    View in: PubMed
    Score: 0.234
  2. Revascularization of the gastroduodenal artery in a pancreas allograft from a donor with a replaced right hepatic artery. Transplantation. 2005 Feb 27; 79(4):503.
    View in: PubMed
    Score: 0.194
  3. Use of non-heart-beating donors. Transplant Proc. 2000 Nov; 32(7):1510-1.
    View in: PubMed
    Score: 0.143
  4. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999 Sep; 5(5):421-8.
    View in: PubMed
    Score: 0.132
  5. Reconstruction of an abnormal hepatic vein in a donor liver: a case report. Transplantation. 1998 May 15; 65(9):1265-6.
    View in: PubMed
    Score: 0.121
  6. Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transpl. 2018 02; 24(2):233-245.
    View in: PubMed
    Score: 0.119
  7. Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C. PLoS One. 2016; 11(11):e0166998.
    View in: PubMed
    Score: 0.109
  8. Cadaveric liver donors; what are the limits? Transplant Proc. 1996 Feb; 28(1):21-3.
    View in: PubMed
    Score: 0.103
  9. The rationale for equitable liver allocation. Clin Transpl. 1996; 325-32.
    View in: PubMed
    Score: 0.103
  10. Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic. Liver Transpl. 2015 Dec; 21(12):1494-503.
    View in: PubMed
    Score: 0.102
  11. Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi-blinded prospective randomized trial. Clin Transplant. 2015 Dec; 29(12):1173-80.
    View in: PubMed
    Score: 0.101
  12. Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant. 2012 Feb; 12(2):306-12.
    View in: PubMed
    Score: 0.078
  13. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant. 2010 Dec; 10(12):2665-72.
    View in: PubMed
    Score: 0.072
  14. Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients? Surgery. 2010 Sep; 148(3):582-8.
    View in: PubMed
    Score: 0.069
  15. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Liver Transpl. 2008 Jan; 14(1):59-65.
    View in: PubMed
    Score: 0.059
  16. Expanding the donor pool: safe transplantation of a cadaveric liver allograft with a 10 cm cavernous hemangioma--a case report. Liver Transpl. 2006 Apr; 12(4):687-9.
    View in: PubMed
    Score: 0.052
  17. Flexible management of enzymatic digestion improves human islet isolation outcome from sub-optimal donor pancreata. Am J Transplant. 2003 Sep; 3(9):1135-42.
    View in: PubMed
    Score: 0.044
  18. Advances in hepatitis B virus infection. Transplant Proc. 2003 Feb; 35(1):342-4.
    View in: PubMed
    Score: 0.042
  19. Highlights of the Festschrift in honor of Thomas E. Starzl, MD, PHD. Am J Transplant. 2002 Jan; 2(1):7-11.
    View in: PubMed
    Score: 0.039
  20. Organ allocation in the United States: where does it stand? Point. J Am Coll Surg. 2001 Jan; 192(1):118-24.
    View in: PubMed
    Score: 0.036
  21. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology. 2000 Mar; 31(3):577-80.
    View in: PubMed
    Score: 0.034
  22. Influence of donor condition on postoperative graft survival and function in human liver transplantation. Transplant Proc. 2000 Mar; 32(2):322-6.
    View in: PubMed
    Score: 0.034
  23. Tc-99m hexamethylpropylene amine oxime scintigraphy in the diagnosis of brain death and its implications for the harvesting of organs used for transplantation. Clin Nucl Med. 2000 Jan; 25(1):7-10.
    View in: PubMed
    Score: 0.034
  24. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation. 1999 Oct 15; 68(7):1058-61.
    View in: PubMed
    Score: 0.033
  25. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation. 1999 Apr 27; 67(8):1191-3.
    View in: PubMed
    Score: 0.032
  26. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. Exp Clin Transplant. 2018 08; 16(4):439-445.
    View in: PubMed
    Score: 0.030
  27. Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients. Am J Transplant. 2018 10; 18(10):2544-2558.
    View in: PubMed
    Score: 0.030
  28. Tolerance and chimerism in liver transplantation. Transplant Proc. 1997 Nov; 29(7):2817-8.
    View in: PubMed
    Score: 0.029
  29. HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation. 1997 Oct 15; 64(7):983-91.
    View in: PubMed
    Score: 0.029
  30. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol. 1997 Feb; 150(2):563-78.
    View in: PubMed
    Score: 0.028
  31. "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation. 1996 Nov 15; 62(9):1242-6.
    View in: PubMed
    Score: 0.027
  32. Role of donor hemodynamic trajectory in determining graft survival in liver transplantation from donation after circulatory death donors. Liver Transpl. 2016 11; 22(11):1469-1481.
    View in: PubMed
    Score: 0.027
  33. Split liver transplantation in adults. World J Gastroenterol. 2016 Sep 07; 22(33):7500-6.
    View in: PubMed
    Score: 0.027
  34. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology. 1996 May; 88(1):124-9.
    View in: PubMed
    Score: 0.026
  35. Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995 Dec; 22(6):1754-62.
    View in: PubMed
    Score: 0.026
  36. Experience with liver and kidney allografts from non-heart-beating donors. Transplant Proc. 1995 Oct; 27(5):2898.
    View in: PubMed
    Score: 0.025
  37. Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant. 2015 Apr; 15(4):923-30.
    View in: PubMed
    Score: 0.024
  38. Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc. 1995 Feb; 27(1):1184-5.
    View in: PubMed
    Score: 0.024
  39. Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995 Feb; 27(1):710-2.
    View in: PubMed
    Score: 0.024
  40. Human islet allograft follow-up: long-term islet function and over 3 years of insulin independence. Transplant Proc. 1994 Apr; 26(2):569.
    View in: PubMed
    Score: 0.023
  41. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol. 1994; 2(1):61-7.
    View in: PubMed
    Score: 0.022
  42. Liver transplantation at Cleveland Clinic. Clin Transpl. 2010; 195-206.
    View in: PubMed
    Score: 0.017
  43. Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology. 2004 Sep-Oct; 51(59):1413-6.
    View in: PubMed
    Score: 0.012
  44. De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004 Jun 15; 77(11):1719-25.
    View in: PubMed
    Score: 0.012
  45. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.
    View in: PubMed
    Score: 0.010
  46. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999 Dec 27; 68(12):1851-4.
    View in: PubMed
    Score: 0.008
  47. [Experience of orthotopic liver transplantation from non-heart-beating donors at the University of Pittsburgh Medical Center]. Nihon Geka Gakkai Zasshi. 1999 Dec; 100(12):818-21.
    View in: PubMed
    Score: 0.008
  48. An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1999 Sep 15; 68(5):650-5.
    View in: PubMed
    Score: 0.008
  49. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999 Feb 15; 67(3):411-5.
    View in: PubMed
    Score: 0.008
  50. Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation. 1999 Jan 27; 67(2):299-303.
    View in: PubMed
    Score: 0.008
  51. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
    View in: PubMed
    Score: 0.007
  52. Outcome of kidney transplantation in African-Americans using tacrolimus. Transplant Proc. 1997 Dec; 29(8):3731-2.
    View in: PubMed
    Score: 0.007
  53. An attempt to reverse diabetes by delayed islet cell transplantation in humans. Transplant Proc. 1997 Jun; 29(4):2238-9.
    View in: PubMed
    Score: 0.007
  54. Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc. 1997 Feb-Mar; 29(1-2):454-5.
    View in: PubMed
    Score: 0.007
  55. Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1184-5.
    View in: PubMed
    Score: 0.007
  56. An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv Exp Med Biol. 1997; 417:269-74.
    View in: PubMed
    Score: 0.007
  57. Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. Transplant Proc. 1995 Feb; 27(1):207-9.
    View in: PubMed
    Score: 0.006
  58. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats. Cell Transplant. 1993 Jul-Aug; 2(4):345-53.
    View in: PubMed
    Score: 0.005
  59. Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 2):888-90.
    View in: PubMed
    Score: 0.005
  60. Survival of human hepatocellular aggregates in athymic mice. Transplant Proc. 1992 Jun; 24(3):986.
    View in: PubMed
    Score: 0.005
  61. Composition of human islet cell preparations for transplantation. Acta Diabetol. 1992; 28(3-4):233-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.